After submitting a bid, in June 2013 Areva Pharmaceuticals was awarded a contract with Apexus for Epirubicin, Irinotecan, and Pamidronate.
Apexus is the contractor for the 340B Prime Vendor Program and works with the Health Resources and Services Administration (HRSA) to help approved hospitals, clinics and other healthcare organizations increase efficiency and reduce costs. The 340B program assists with discounts on pharmaceuticals and services for hospitals and clinics to expand access to healthcare for low-income and vulnerable members of the population.
Please direct all media inquiries to:
Customer Service firstname.lastname@example.org